Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia

Leukemia

Volumn 11, Issue 8, 1997, Pages 1234-1237

  Fielder, W ^a   Graeven, U ^a,b   Ergun S ^a   Verago, S ^c   Kilic, N ^a   Stockschlader M ^a   Hossfeld, D K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c Eppendorf ^*

Author keywords

AML; Angiogenesis; FLT4; VEGF C

Indexed keywords

CD34 ANTIGEN; GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; BONE MARROW CELL; CANCER DIAGNOSIS; CANCER RECURRENCE; CELL GROWTH; CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL LINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030923575     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400722     Document Type: Article

References (20)

1. Rosnet O, Birnbaum D. Hematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncogen 1993; 4: 595-613.
2. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995; 129: 895-898.
3. Drexler HG. Expression of FLT3 receptor and response to FLT3 ligand by leukemia cells. Leukemia 1996; 10: 588-599.
4. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298.
5. Rousset D, Agnes F, Lachaume P, André C, Galibert F. Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains. J Mol Evol 1995; 41: 421-429.
6. Armstrong E, Kastury K, Aprelikova O, Bullrich F, Nezelof C, Gogusev J, Wasmuth JJ, Alitalo K, Morris S, Huebner K. FLT4 receptor tyrosine kinase gene mapping to chromosome band 5q35 in relation to the t(2;5), t(5;6), and t(3;5) translocations. Genes Chromosom Cancer 1993; 7: 144-151.
7. Borg JP, de Lapeyriere O, Noguchi T, Rottapel R, Dubreuil P, Birnbaum B. Biochemical characterisation of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 1995; 10: 973-984.
8. Pajusola K, Aprelikova O, Armstrong E, Morris S, Alitalo K. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 1993; 8: 2931-2937.
9. Fournier E, Dubreuil P, Birnbaum D, Borg JP. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of FLT4 receptor. Oncogene 1995; 11: 921-931.
10. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K, Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566-3570.
11. Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, McMahon J, Wasmuth J, Huebner K, Alitalo K. FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 1992; 52: 746-748.
12. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1992; 52: 5738-5743.
13. Davidoff MS, Schulze W. Combination of the peroxidase antiperoxidase (PAP)- and avidin-biotin-peroxidase complex. (ABC) techniques: an amplification alternative in immunohistochemical staining. Histochemistry 1990; 93: 531-536.
14. Davidoff MS, Middendorf R, Meyer B, Holstein AF. Nitric oxide synthase (NOS-I) in Leydig cells of the human testis. Arch Histol Cytol 1995; 58: 17-30.
15. Itoh Z, Akiva K, Namura S, Miguno N, NAkamura Y, Sugimoto T. Application of coupled oxidation reaction to electron microscopic demonstration of horseradish peroxidase: cobalt-glucose oxidase method. Brain Res 1979; 175: 341-346.
16. Záborszky L, Léránth C. Simultaneous ultrastructural demonstration of retrogradlly transported horseradish peroxidase and choline acetyl-transferase immunoreactivity. Histochemistry 1985; 82: 529-537.
17. Dilly SA, Jagger CJ. Bone marrow stromal cell changes in haematological malignancies. J Clin Pathol 1990; 43: 942-946.
18. Vacca A, Ribatti D, Roncalli L, Ranieri G, Serio G, Silvestris F, Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503-508.
19. Oster W, Mertelsmann R, Herrmann F. Role of colony-stimulating factors in the biology of acute myelogenous leukemia. Int J Cell Clon 1989; 7: 13-29.
20. Griffin JD, Rambaldi A, Vellenga E, Young DC, Ostapovicz D, Cannistra SA. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood 1987; 70: 1218-1221.